-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
eFFECTOR Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q3 2020 to Q1 2024.
- eFFECTOR Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $19K, a 35.7% increase year-over-year.
- eFFECTOR Therapeutics, Inc. Operating Lease, Payments for the twelve months ending March 31, 2024 was $105K, a 9.38% increase year-over-year.
- eFFECTOR Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $100K, unchanged from 2022.
- eFFECTOR Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $100K, unchanged from 2021.
- eFFECTOR Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $100K, a 85.7% decline from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)